You are in: eMedicine Specialties > Emergency Medicine > Infectious Diseases
|
Breast Abscess and Masses Last Updated: October 27, 2005 |
|
| Synonyms and related keywords: breast mass, breast abscess, malignant breast disease, benign breast mass, malignant breast mass, breast lump, breast cancer, mastitis, postpartum mastitis, in situ lobular or ductal cancer, intraductal papilloma, infiltrating ductal carcinoma, inflammatory carcinoma, fibroadenoma
|
|   |
AUTHOR INFORMATION
| Section 1 of 10  |
|
| Author: Howard A Blumstein, MD, FAAEM, Assistant Professor, Surgery; Medical Director, Department of Emergency Medicine, Wake Forest University School of Medicine Coauthor(s): Amy K Rontal, MD, Clinical Instructor, Department of Emergency Medicine, University of Michigan Health System |
| Howard A Blumstein, MD, FAAEM, is a member of the following medical societies:
American Academy of Emergency Medicine,
American College of Emergency Physicians,
American Medical Association,
Emergency Medicine Residents' Association, and
Society for Academic Emergency Medicine |
| Editor(s): David FM Brown, MD, Assistant Professor, Department of Medicine, Division of Emergency Medicine, Harvard Medical School; Vice-Chair, Department of Emergency Medicine, Massachusetts General Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine;
Barry J Sheridan, DO, Chief, Department of Emergency Medical Services, Brooke Army Medical Center;
John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School;
and Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School |
Disclosure
|   |
INTRODUCTION
| Section 2 of 10  |
|
Background: Patients typically do not present in the ED with a breast mass as their chief complaint; however, knowledge of the pertinent anatomy, pathophysiology, and clinical clues is essential.
Breast masses can be broadly classified as benign or malignant. Common causes of benign breast masses include fibrocystic disease, fibroadenoma, and abscess. Malignant breast disease encompasses many histologic types that include, but are not limited to, in situ lobular or ductal cancer, intraductal papilloma, infiltrating ductal carcinoma, and inflammatory carcinoma. The main concern of many women presenting with a breast mass is the likelihood of cancer; however, most breast masses are benign.
Pathophysiology: Breast masses can involve any of the tissues that make up the breast, including overlying skin, ducts, lobules, and connective tissues. Fibrocystic disease, the most common breast mass in women, is found in 60-90% of breasts during routine autopsy. Fibroadenoma, the most common benign tumor, typically affects women younger than 30 years. Infiltrating ductal carcinoma is the most common malignant tumor. Inflammatory carcinoma is the most aggressive malignant tumor and carries the worst prognosis.
The breast is a modified sweat gland with multiple secretory acini that drain into lactiferous ducts. These ducts are grouped into lobules, which are demarcated by Cooper ligaments. Each of the lobule secretory ducts converge to form one ampulla, which traverses the nipple to open at the apex. When the lactiferous duct lining undergoes epidermalization, keratin production can cause plugging of the duct and result in abscess formation. This helps explain the high recurrence rate (an estimated 39-50%) of breast abscesses in patients treated with standard incision and drainage (I&D). This technique does not address the basic mechanism by which breast abscesses are thought to occur.
Postpartum mastitis is a localized cellulitis caused by bacterial invasion through an irritated or fissured nipple. It typically occurs after the second postpartum week and is precipitated by milk stasis. Frequency:
- In the US: One out of every 8 women is diagnosed with breast cancer during her lifetime. Breast abscess is more common in nonlactating (nonpuerperal) women than in women who are lactating. One study found that, over a 10-year period, 8.5% of 72 women presenting with a breast abscess were in puerperium. Postpartum mastitis occurs in 1-5% of lactating women.
Mortality/Morbidity:
- Breast mass: Morbidity and mortality depends on pathology of the mass. Approximately 1 in 28 (3.6%) women die from breast cancer. Associated morbidity may include scarring, disfigurement, and lymphedema.
- Breast abscess: Recurrent or chronic infections, pain, and scarring are causes of morbidity.
- Mastitis: Abscess formation is a complication of postpartum mastitis in fewer than 10% of individuals affected.
Race: Premenopausal breast cancer is more likely to develop in black women than white women. This is not true during the postmenopausal period.
Sex: Breast masses are overwhelmingly a disease of women.
Age: Women older than 40 years account for more than 80% of breast cancer patients. The median age of diagnosis is 64 years.
- Nonpuerperal breast masses encompass the third to eighth decades of life.
- Puerperal breast abscesses and mastitis are commonly found in women of childbearing age.
- Fibroadenoma is the most common cause of breast mass in women up to age 35 years.
|   |
CLINICAL
| Section 3 of 10  |
|
History: - Palpable mass, typically only in one breast
- Family history of breast disease, malignant and benign
- Menstrual and obstetrical histories
- Associated symptoms of pain, nipple discharge, and skin changes (eg, dimpling or inflammation, nipple inversion)
- Length of time present, speed of growth
- No history at all if the mass is found during physical examination
- Localized breast area edematous, erythematous, warm, and painful
- History of previous breast abscess
- Associated symptoms of fever, vomiting, and spontaneous drainage from the mass or nipple
- Localized breast area erythematous, warm, and painful
- May have fever and chills
- May be lactating and may have recently missed feedings
Physical: Perform a thorough breast examination for any patient presenting with a breast complaint and any older woman presenting with unexplained weight loss, anorexia, or bone pain. Talk through the examination, giving extra instruction on how and when patients can perform breast self-examination at home. - Firm mass of variable shape and size
- Fifty percent of masses found in the upper outer quadrant of the breast
- May have associated pain with palpation, but most are painless
- Skin retraction or tethering
- Inflammatory changes of the skin (ie, peau d'orange)
- Localized breast area erythematous, hot, edematous, and extremely painful
- Most commonly found in the areolar or periareolar area
- May have associated fever or axillary lymphadenopathy
- Discharge with palpation from nipple or mass
- Localized breast area erythematous, warm, indurated, and tender
- May have associated fever
Causes: - Risk factors for breast cancer include female sex, age older than 40 years, family history of breast cancer, nulliparity, menarche before age 12, menopause after age 55, and late pregnancy.
- The BRCA gene is responsible for 5% of all breast cancers and is inherited in an autosomal dominant fashion. Of those with the gene, 60% develop breast cancer by age 50 years.
- Staphylococcus aureus and streptococcal species are the most common organisms isolated in puerperal breast abscesses. Nonpuerperal abscesses typically contain mixed flora (S aureus, streptococcal species) and anaerobes.
- A study by Schafer et al found a significant correlation between cigarette smoking and subareolar breast abscess.
- S aureus is most common cause, typically originating from the nursing child. Streptococci, enterococci, Staphylococcus epidermidis, and Escherichia coli are less common.
|   |
DIFFERENTIALS
| Section 4 of 10  |
|
Cellulitis
Other Problems to be Considered:
Breast cancer Fibroadenoma Fibrocystic disease Fat necrosis Mastitis |
|
|   |
WORKUP
| Section 5 of 10  |
|
Lab Studies:
- In patients suspected of having a breast abscess, a CBC with differential can be helpful. An aerobic and anaerobic culture may be taken in the operating room.
Imaging Studies:
- Perform ultrasonography to determine solid versus cystic structures in the breast and to direct needle aspiration for abscess drainage.
- Schedule a mammography (criterion standard for breast mass evaluation) as an outpatient study to further define the suspected breast mass.
Procedures:
- Some argue that needle aspiration of a breast abscess is a successful method of treatment. However, this procedure is probably best left to a surgeon because multiple aspirations over time are necessary for complete resolution.
- For many years, I&D has been the standard of care for abscesses. However, simple I&D does not treat the underlying cause of the breast abscess, and it may result in a high number of recurrences.
|   |
TREATMENT
| Section 6 of 10  |
|
Emergency Department Care: - Definitive diagnosis of the etiology can only be made by pathologic examination and is not an emergency. Timely follow-up care, including mammography and involvement of primary physician and surgeon, is essential.
- Finding a breast mass can be stressful for patients; provide reassurance that not all breast masses are malignant.
- Breast abscess: Identify the problem and provide pain control, antibiotic therapy, and prompt surgical consultation.
- Mastitis: Treat with antistaphylococcal antibiotics, warm compresses, and continued emptying of the breast by breastfeeding or breast pumping.
Consultations: - Patients with breast masses need to be seen by a general surgeon for definitive treatment. Immediate consultation in the ED is not mandatory, but it may help facilitate faster follow-up care once patients are discharged from the hospital.
- Patients with suspected breast abscess should be seen by a surgeon for definitive care.
|   |
MEDICATION
| Section 7 of 10  |
|
The goal of therapy is to eradicate the infection and minimize complications.
Drug Category: Antibiotics -- Therapy must cover all likely pathogens in the context of the clinical setting. Drug Name
| Nafcillin (Unipen) -- DOC for puerperal breast abscess. Treats infections caused by penicillinase-producing staphylococci. Used to initiate therapy when a penicillin G–resistant staphylococcal infection is suspected.
Because of occasional occurrence of thrombophlebitis associated with parenteral route (particularly in elderly persons), administer parenterally only for a short term (24-48 h) and change to PO if clinically possible.| Adult Dose | 2 g IV q4h |
|---|
| Pediatric Dose | 150 mg/kg/d IV divided q6h |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Associated with warfarin resistance when administered concurrently; effects may decrease with bacteriostatic action of tetracycline derivatives |
|---|
| Pregnancy |
B - Usually safe but benefits must outweigh the risks.
|
|---|
| Precautions | To optimize therapy, determine causative organisms and susceptibility; >10 d treatment to eliminate infection and prevent sequelae (eg, endocarditis, rheumatic fever); take cultures after treatment to confirm that infection is eradicated |
|---|
| Drug Name
| Vancomycin (Vancocin, Vancoled, Lymphocin) -- DOC for patients with puerperal breast abscess who are penicillin allergic. Potent antibiotic directed against gram-positive organisms and active against enterococcal species. Useful in treatment of septicemia and skin structure infections. Indicated for patients who cannot receive, or have failed to respond to, penicillins and cephalosporins or who have infections with resistant staphylococci.
To avoid toxicity, current recommendation is to assay vancomycin trough levels after the third dose drawn 0.5 h before next dosing. Use CrCl to adjust dose in renal impairment, prn.| Adult Dose | 1 g IV q12h |
|---|
| Pediatric Dose | 40 mg/kg IV tid/qid |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Erythema, histaminelike flushing and anaphylactic reactions may occur when administered with anesthetic agents; taken concurrently with aminoglycosides, risk of nephrotoxicity may increase above that with aminoglycoside monotherapy; effects in neuromuscular blockade may be enhanced when coadministered with nondepolarizing muscle relaxants |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Caution in renal failure and neutropenia; red man syndrome is caused by too rapid IV infusion (dose administered over a few minutes) but rarely happens when dose given as 2-hour administration or as PO or IP administration; red man syndrome is not an allergic reaction |
|---|
|
|---|
Drug Name
| Clindamycin (Cleocin) -- DOC for nonpuerperal breast abscess. An alternate DOC for patients with mastitis who are penicillin allergic.
A lincosamide useful as treatment against serious skin and soft tissue infections caused by most staphylococcal strains. Also effective against aerobic and anaerobic streptococci, except enterococci.
Inhibits bacterial protein synthesis by inhibiting peptide chain initiation at the bacterial ribosome where it preferentially binds to the 50S ribosomal subunit, causing bacterial growth inhibition.| Adult Dose | 300 mg IV/PO q6h |
|---|
| Pediatric Dose | 20-40 mg/kg IV/IM tid/qid |
|---|
| Contraindications | Documented hypersensitivity; regional enteritis, ulcerative colitis, hepatic impairment, antibiotic-associated colitis |
|---|
| Interactions | Increases duration of neuromuscular blockade, induced by tubocurarine and pancuronium; erythromycin may antagonize effects; antidiarrheals may delay absorption |
|---|
| Pregnancy |
B - Usually safe but benefits must outweigh the risks.
|
|---|
| Precautions | Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis |
|---|
|
|---|
Drug Name
| Ampicillin-sulbactam sodium (Unasyn) -- Alternative DOC for nonpuerperal breast abscess. Drug combination that utilizes a beta-lactamase inhibitor with ampicillin. Covers skin, enteric flora, and anaerobes. Not ideal for nosocomial pathogens. |
|---|
| Adult Dose | 1.5 (1 g ampicillin + 0.5 g sulbactam) to 3 g (2 g ampicillin + 1 g sulbactam) IV/IM q6-8h; not to exceed 4 g/d sulbactam or 8 g/d ampicillin |
|---|
| Pediatric Dose | 3 months to 12 years: 100-200 mg ampicillin/kg/d (150-300 mg Unasyn) IV divided q6h
>12 years: Administer as in adults; not to exceed 4 g/d sulbactam or 8 g/d ampicillin| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Probenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives |
|---|
| Pregnancy |
B - Usually safe but benefits must outweigh the risks.
|
|---|
| Precautions | Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction |
|---|
|
|---|
Drug Name
| Dicloxacillin (Dycill, Dynapen) -- DOC for mastitis. Bactericidal antibiotic that inhibits cell wall synthesis. Used to treat infections caused by penicillinase-producing staphylococci. May be used to initiate therapy when a staphylococcal infection is suspected. |
|---|
| Adult Dose | 500 mg PO qid |
|---|
| Pediatric Dose | 12-25 mg/kg/d PO divided qid |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Decreases efficacy of oral contraceptives; increases effects of anticoagulants; probenecid and disulfiram may increase penicillin levels |
|---|
| Pregnancy |
B - Usually safe but benefits must outweigh the risks.
|
|---|
| Precautions | Monitor PT in patients taking anticoagulant medications; toxicity may increase in renal impairment |
|---|
Drug Name
| Oxacillin (Bactocill, Prostaphlin) -- Bactericidal antibiotic that inhibits cell wall synthesis. Used in the treatment of infections caused by penicillinase-producing staphylococci. May be used to initiate therapy when a staphylococcal infection is suspected. |
|---|
| Adult Dose | 500-1000 mg PO q4-6h 150-200 mg/kg/d IM/IV divided q6h |
|---|
| Pediatric Dose | 50-100 mg/kg/d PO divided q6h 150-200 mg/kg/d IM/IV divided q6h; not to exceed 12 g/d |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Oxacillin decreases effects of contraceptives and tetracycline; administered concomitantly with disulfiram and probenecid, may increase oxacillin levels; effect of anticoagulants increase with large IV doses of oxacillin |
|---|
| Pregnancy |
B - Usually safe but benefits must outweigh the risks.
|
|---|
| Precautions | Caution in impaired renal function |
|---|
|   |
FOLLOW-UP
| Section 8 of 10  |
|
Further Inpatient Care:
- Admit patients suspected of having a breast abscess for pain management, parenteral antibiotic therapy, and definitive management.
- Treatment is likely to include incision, drainage, and fistulectomy in the operating room.
- The wound can be left to close by secondary intention or with simple sutures over a drain.
Further Outpatient Care:
- Breast mass - Timely follow-up with primary physician and surgeon, mammography, and possible needle biopsy of the mass
- Mastitis - Antibiotic therapy for 7-10 days, warm compresses, and continued breast emptying by breastfeeding or breast pumping; instruct patients who are lactating that continued breastfeeding from the affected breast is not harmful to babies
In/Out Patient Meds:
- Prescribe pain medication to patients with a breast abscess as necessary. NSAIDs, Tylenol with codeine, or Tylenol with oxycodone are good choices, depending on the level of discomfort.
- Prescribe parenteral narcotics for pain control while awaiting definitive surgical therapy.
- Continue antibiotic therapy for 14 days after drainage.
Transfer:
- Transfer typically is not necessary for patients with breast mass, abscess, or mastitis.
Complications:
- Breast mass - Chronic pain, scarring or disfigurement, metastases, postsurgical complications (eg, lymphedema of the ipsilateral arm), and death
- Breast abscess - Recurrent or chronic infection, scarring
- Mastitis - Breast abscess formation in less than 10% of cases
Prognosis:
- Breast mass: Prognosis varies from excellent in patients with a fibroadenoma to poor in those with inflammatory breast cancer. Influencing factors include tumor size, histology, nodal involvement, distant metastases, and comorbid conditions.
- Breast abscess: Unfortunately, the recurrence rate of breast abscess is high (39-50% when treated with standard I&D). Studies of patients with fistulectomy have lower recurrence rates.
- Mastitis: Most patients have resolutions of infection in 2-3 days.
Patient Education:
- Educate women who are lactating on nipple hygiene because cracking and abrasions of the skin increase risk of infection.
- Instruct all women on the correct way to perform breast self-examination.
|   |
MISCELLANEOUS
| Section 9 of 10  |
|
Medical/Legal Pitfalls:
- Failure to arrange proper follow-up care for patients with newly diagnosed breast mass
- Failure to recognize need for drainage in patients with breast abscess
|   |
BIBLIOGRAPHY
| Section 10 of 10 |
|
-
August DA, Sondak VK: Breast. In: Greenfield LJ, et al, eds. Surgery Scientific Principles and Practice, 2nd ed. Lippincott-Raven Publishers; 1997: 1357-1415.
-
Dener C, Inan A: Breast abscesses in lactating women. World J Surg 2003 Feb; 27(2): 130-3[Medline].
-
Dixon JM: Repeated aspiration of breast abscesses in lactating women. BMJ 1988 Dec 10; 297(6662): 1517-8[Medline].
-
Dixon JM: Outpatient treatment of non-lactational breast abscesses. Br J Surg 1992 Jan; 79(1): 56-7[Medline].
-
Eley JW, Hill HA, Chen VW, et al: Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994 Sep 28; 272(12): 947-54[Medline].
-
Harris JR, Lippman ME, Veronesi U, and Willett W: Breast cancer (1). N Engl J Med 1992 Jul 30; 327(5): 319-28[Medline].
-
Karstrup S, Solvig J, Nolsoe CP, et al: Acute puerperal breast abscesses: US-guided drainage. Radiology 1993; 188: 807-9[Medline].
-
Khoda J, Lantsberg L, Yegev Y, and Sebbag G: Management of periareolar abscess and mamillary fistula. Surg Gynecol Obstet 1992 Oct; 175(4): 306-8[Medline].
-
Kitchen PR: Management of sub-areolar abscess and mammary fistula. Aust N Z J Surg 1991 Apr; 61(4): 313-5[Medline].
-
Maier WP, Au FC, Tang CK: Nonlactational breast infection. Am Surg 1994 Apr; 60(4): 247-50[Medline].
-
Meguid MM, Oler A, Numann PJ, Khan S: Pathogenesis-based treatment of recurring subareolar breast abscesses. Surgery 1995 Oct; 118(4): 775-82[Medline].
-
Miller BA, Feuer EJ, Hankey BF: The significance of the rising incidence of breast cancer in the United States. Important Adv Oncol 1994; 193-207[Medline].
-
O'Hara RJ, Dexter SP, Fox JN: Conservative management of infective mastitis and breast abscesses after ultrasonographic assessment. Br J Surg 1996 Oct; 83(10): 1413-4[Medline].
-
Walker AP, Edmiston CE, Krepel CJ, et al: A prospective study of the microflora of nonpuerperal breast abscess. Arch Surg 1988; 123: 908-11[Medline].
-
Watt-Boolsen S, Rasmussen NR, Blichert-Toft M: Primary periareolar abscess in the nonlactating breast: risk of recurrence. Am J Surg 1987 Jun; 153(6): 571-3[Medline].
-
Wiesenfeld HC, Sweet RL: Perinatal infections. In: Scott JR, et al, eds. Danforth's Obstetrics and Gynecology. 7th ed. Lippincott-Raven Publishers; 1994:469.
Breast Abscess and Masses excerpt |